Randomised controlled trialindependent cross-checkabstract checked I-DRY-125 standard review

Six weeks of more dairy did not raise the main inflammation marker

Inflammatory Cytokine Responses to 6 Wks of Increased Dairy Intake in Individuals with Overweight and Obesity-A Randomized Crossover Trial.

Overview

Prowting JL et al.. J Nutr 2026 · PMID 41176279 · DOI 10.1016/j.tjnut.2025.10.040

IL-6 unchanged; TNF-alpha down; men showed some opposite changes.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Test dairy and inflammation in people with obesity.

How was the study done?

Randomised crossover trial.

How many people, animals or samples were studied?

30 adults.

What was actually found?

No rise in IL-6; some markers improved.

How large was the observed effect?

TNF-alpha P=0.042.

What do the results mean in everyday life?

Dairy did not inflame on average.

What are the study's limitations?

Small, short; industry links.

What does it say about Elawady's specific claim?

Contradicts the claim on average.

Do the results apply to Germany and Europe?

Applicable.

What can explicitly not be concluded from this study?

Cannot show long-term effects.

Scientific in-depth review

1. Full reference

Authors
Prowting JL et al.
Journal
J Nutr
Year
2026
Identifier
PMID 41176279 DOI 10.1016/j.tjnut.2025.10.040
Verification
verified – PubMed efetch 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

Several authors report funding/advisory relationships with Dairy Farmers of Canada; supplies from Lactalis Canada; public grants (CIHR, NSERC).

2. Research question

Does a high mixed-dairy diet change inflammatory, metabolic and vascular markers compared with a low-dairy diet?

3. Study design and population

Study design
Randomised controlled trial – Randomised crossover trial, two 6-week periods, >=4-week washout (NCT04902417)
Population

Adults with overweight/obesity and cardiometabolic risk factors (Canada)

Country

Canada

Period

not stated

Sample size

30 (18 women, 12 men)

Inclusion and exclusion criteria

BMI overweight/obese with cardiometabolic risk factors; habitually low dairy

4. Methods and endpoints

Exposure / intervention

3 servings/day of low-fat milk, Skyr yogurt, full-fat cheddar

Comparator

Habitual low-dairy diet (<=1 serving/day)

Endpoints

IL-6 (primary), TNF-alpha, IL-4, metabolic and vascular markers

Statistical methods

Mixed models adjusted for age, BMI, sequence, period

5. Actual results

Results

No condition-by-time interaction for IL-6 (primary endpoint); TNF-alpha decreased (P=0.042) and IL-4 increased (P=0.026) on the high-dairy diet; no metabolic, vascular, weight or fat changes. Sex-by-condition interactions: IL-6, TNF-alpha, triglycerides and diastolic blood pressure higher during the high-dairy condition in males.

Absolute risks

not reported

Authors' conclusion

Increasing mixed dairy intake for 6 weeks favourably modulated some cytokines without metabolic, vascular or body-composition changes; sex differences need further study.

6. Strengths

  • Randomised crossover
  • Whole-food dairy including yogurt and cheese

7. Weaknesses

  • Small, short
  • Dairy-industry links
  • Primary endpoint null; secondary and subgroup findings exploratory
  • Opposite signals in men

8. Risk of bias

Orienting tool
RoB 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Industry links; multiplicity.

9. Assessment of the statistical interpretation

Primary outcome null; secondary P values near 0.04 without multiplicity correction.

10. Relevance to the specific claim

A recent RCT found no increase in the primary inflammation marker with 3 daily dairy servings (milk, yogurt, cheese); some markers improved, but men showed less favourable changes.

11. Independent contrary findings

Male subgroup signal; A-DRY-01 cross-sectional data.

12. Transferability to Germany and Europe

Canadian adults with obesity.

13. Overall methodological judgement

Low-certainty support for 'no general pro-inflammatory effect'.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultslow
Directnessdirect
Reproducibilitynot replicated
Consistency with the overall evidencemixed
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Sex differences.

15. Linked fact checks